• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

2.375 -0.195 (-7.59%)
Streaming Delayed Price Updated: 1:47 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,385
Open 2.500
Bid (Size) 2.360 (28)
Ask (Size) 2.390 (7)
Prev. Close 2.570
Today's Range 2.340 - 2.570
52wk Range 1.620 - 14.67
Shares Outstanding 2,968,444
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 13, 2025
 
Via Benzinga
Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025
October 10, 2025
Via ACCESS Newswire

Performance

YTD
-71.2%
-71.2%
1 Month
+12.6%
+12.6%
3 Month
+10.0%
+10.0%
6 Month
+34.9%
+34.9%
1 Year
-8.4%
-8.4%

More News

Read More
Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium
September 04, 2025
Via ACCESS Newswire
Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
August 19, 2025
Via ACCESS Newswire
Ensysce Biosciences Narrows Loss in Q2
August 13, 2025
Via The Motley Fool
Topics Intellectual Property
Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection
June 04, 2025
Via ACCESS Newswire
Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates
August 13, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 31, 2025
Via Benzinga
Ensysce Biosciences Advances Breakthrough Opioid With Built-In Overdose Protection Following Positive FDA Feedback
July 31, 2025
Via ACCESS Newswire
These stocks that are showing activity before the opening bell on Wednesday.
July 23, 2025
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 23, 2025
Via Benzinga
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
July 16, 2025
Via ACCESS Newswire
Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
June 24, 2025
Via ACCESS Newswire
Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025
June 11, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
May 16, 2025
Via Benzinga
Ensysce Biosciences Reports First Quarter 2025 Financial Results
May 13, 2025
Via ACCESS Newswire
Ensysce Biosciences Bolsters Management Team with Regulatory Expert
May 12, 2025
Via ACCESS Newswire
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 24, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 24, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 24, 2025
Via Benzinga
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
April 24, 2025
Via Benzinga
Top movers in Wednesday's after hours session
April 23, 2025
Via Chartmill
Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why
April 23, 2025
Via Benzinga
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 23, 2025
Via Benzinga
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Ensysce Biosciences, Inc. - Common Stock publicly traded?
Yes, Ensysce Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ensysce Biosciences, Inc. - Common Stock trade on?
Ensysce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ensysce Biosciences, Inc. - Common Stock?
The ticker symbol for Ensysce Biosciences, Inc. - Common Stock is ENSC on the Nasdaq Stock Market
What is the current price of Ensysce Biosciences, Inc. - Common Stock?
The current price of Ensysce Biosciences, Inc. - Common Stock is 2.375
When was Ensysce Biosciences, Inc. - Common Stock last traded?
The last trade of Ensysce Biosciences, Inc. - Common Stock was at 10/17/25 01:47 PM ET
What is the market capitalization of Ensysce Biosciences, Inc. - Common Stock?
The market capitalization of Ensysce Biosciences, Inc. - Common Stock is 7.05M
How many shares of Ensysce Biosciences, Inc. - Common Stock are outstanding?
Ensysce Biosciences, Inc. - Common Stock has 7M shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap